Bioinvent International AB

BioInvent International is a unique company dedicated to working with clients to ensure their success in the discovery, development and manufacture of antibody drugs. The discovery of new drug targets and therapeutics to attack them, is the key to the development of new medicines. Antibody molecules constitute the basis of an important wave of new drugs and are indispensable tools for characterising new targets.

Contact Details: Solvegatan 41 Lund SE-223 Sweden Tel: +46-46-286 8550 Fax: +46-46-211 0806 Email: svein.mathisen@bioinvent.com WWW: www.bioinvent.com/

Recent Publications by Bioinvent International AB:
Targeting angiogenesis with antibodies for the treatment of cancer. The treatment of cancer by targeting angiogenesis and depriving growing...	15th December, 2005	BioInvent International AB, Solvegaten 41, SE-223 70 Lund, Sweden.	IDrugs. 2005 Sep;8(9):730-3.
Human monoclonal antibodies specific for the tumour associated Thomsen-Friedenreich antigen. Five hybridomas producing human monoclonal antibodies (MAbs) of IgA and...	20th June, 2000	BioInvent International AB, Lund, Sweden.	Int J Cancer. 1997 Jan 6;70(1):63-71.

BioNews Results for Bioinvent International AB:
Roche could be eyeing takeover of Swedish BioInvent	Individual.com:  Nov 20 2009 8:41AM Matching: bioinvent international ab
US and European market for radiopharmaceuticals continues to gain momentum	News-Medical.Net:  Nov 20 2009 8:12AM Matching: bioinvent international ab
Paper says Roche might be tempted to buy Swedish BioInvent	ADP News:  Nov 19 2009 8:48AM Matching: bioinvent international ab
Roche could be eyeing takeover of Swedish BioInvent	RBC Dain Rauscher:  Nov 19 2009 11:51AM Matching: bioinvent international ab
BioInvent and ThromboGenics NV Win 'Licensing Deal of the Year' at the Scrip Awards 2009	BioSpace:  Nov 19 2009 9:51PM Matching: bioinvent international ab
Promote your company here: BioNewsCast - Press Release Distribution	→View more Bioinvent International AB news.

Bioinvent International AB Clinical Trials:
Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours

Bioinvent International AB Patents:
US Patent No.	Title
7521046	Antibody immunization therapy for treatment of atherosclerosis
7432083	Method for in vitro molecular evolution of protein function
6989250	Method for in vitro molecular evolution of protein function
6607881	Combined ligand and receptor display
6495321	Method for in vitro molecular evolution of protein function
→View more Bioinvent International AB patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 426 times since April 2007, the link to the organisation's website has been followed 73 times

Recent Search Terms used to find this page: bioinvent international news | bioinvent international | BioInvent | BIOINVENT INTERNATIONAL 223 70 LUND | BIOINVENT INTERNATIONAL 223 70 LUND | .

Search for more companies in Lund

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Bioinvent International AB